Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy (Q46738253)

24 December 2017

title

Impact of CYP2D6*10 on recurrence-free survival in breast cancer patients receiving adjuvant tamoxifen therapy (English)

1 reference

24 December 2017

0 references

1 reference

7

Michiaki Kubo

1 reference

24 December 2017

Yūsuke Nakamura

8

Yusuke Nakamura

1 reference

24 December 2017

Hitoshi Zembutsu

9

Hitoshi Zembutsu

1 reference

24 December 2017

Naoya Hosono

6

Naoya Hosono

1 reference

24 December 2017

Mitsunori Sasa

3

Mitsunori Sasa

1 reference

24 December 2017

Kazuma Kiyotani

1

Kazuma Kiyotani

1 reference

24 December 2017

author name string

Taisei Mushiroda

2

1 reference

24 December 2017

Yoshimi Bando

4

1 reference

24 December 2017

Ikuko Sumitomo

5

1 reference

24 December 2017

publication date

24 February 2008

1 reference

24 December 2017

published in

Cancer Science

1 reference

24 December 2017

volume

99

1 reference

24 December 2017

page(s)

995-999

1 reference

24 December 2017

issue

5

1 reference

24 December 2017

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

CYP2D6.10 present in human liver microsomes shows low catalytic activity and thermal stability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

Quantitative justification of the change from 10% to 30% for human epidermal growth factor receptor 2 scoring in the American Society of Clinical Oncology/College of American Pathologists guidelines: tumor heterogeneity in breast cancer and its impl

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

A high-throughput SNP typing system for genome-wide association studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

Breast cancer treatment outcome with adjuvant tamoxifen relative to patient CYP2D6 and CYP2C19 genotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2008.00780.X

10.1111/J.1349-7006.2008.00780.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18294285

1 reference

24 December 2017